Conference Coverage
Conference Coverage
EMA Greenlights Four Drugs for Bladder and Other Cancers
Among the drug approvals the CHMP endorsed was Balversa for the treatment of urothelial carcinoma.
Conference Coverage
AML: Shorter Venetoclax Course Shows Promise for Some
A 7+7 course of azacitidine and venetoclax shows promise versus standard therapy for certain patients with acute myeloid leukemia.
Conference Coverage
B-ALL: New Findings Confirm Efficacy of CAR T Product
Fresh research presented at ASCO 2024 establishes obe-cel, a CAR T product, as a standard-of-care treatment for adults with R/R B-ALL.
Conference Coverage
MUC-1 vaccine associated with notable overall survival rates in breast cancer
Patients with HER2-negative early breast cancer receive preoperative standard of care neoadjuvant treatment with or without tecemotide, in new...
Conference Coverage
Hemophilia: Marstacimab Sustains Long-Term Bleeding Reduction
In an interim analysis, this novel, weekly subcutaneous injection shows continued benefits in the prevention of bleeding in hemophilia A and B.
Conference Coverage
Thermal Ablation Tops Surgery for Small CRC Liver Mets
The benefit of thermal ablation was so substantial that the trial was stopped early.
Conference Coverage
Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
Conference Coverage
Experts Focus on Quality-of-Life Data in Prostate Cancer
Trials presented at ASCO explore the effects of treatment suspension or intensification on health-related QoL and interventions to manage side...
Conference Coverage
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Study results settle a long-standing debate about whether chemotherapy with FLOT before and after surgery, or neoadjuvant radiation plus CROSS...
Conference Coverage
Platinum Add-On Improves Survival in Early TNBC
Trial outcomes provide strong evidence for incorporating carboplatin into both the neoadjuvant and adjuvant settings in patients with early-stage...
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.